Assignee
ADAGENE INC
KY12 patents
Top patents by PatentIndex Score
US11242395B2Feb 8, 2022
Anti-CD137 molecules and use thereof
ADAGENE INC13 citations91
US11859003B2Jan 2, 2024
Method for treating cancer using anti-CD137 antibody
ADAGENE INC3 citations72
US11359016B2Jun 14, 2022
Anti-CTLA4 antibodies and methods of making and using the same
ADAGENE INC5 citations68
US12385162B2Aug 12, 2025
Dynamic human heavy chain antibody libraries
ADAGENE INC0 citations61
US11585014B2Feb 21, 2023
Dynamic human antibody light chain libraries
ADAGENE INC2 citations61
US11578426B2Feb 14, 2023
Dynamic human heavy chain antibody libraries
ADAGENE INC1 citations61
US12378319B2Aug 5, 2025
Anti-CD137 molecules and use thereof
ADAGENE INC0 citations60
US12054548B2Aug 6, 2024
Anti-PD-L1 antibodies and use thereof
ADAGENE INC0 citations60
US11952681B2Apr 9, 2024
Masked activatable CD137 antibodies
ADAGENE INC1 citations60
US11692036B2Jul 4, 2023
Anti-CTLA4 antibodies and methods of making and using the same
ADAGENE INC0 citations57
US12503693B2Dec 23, 2025
Integrated system for library construction, affinity binder screening and expression thereof
ADAGENE INC0 citations50
US11485977B2Nov 1, 2022
Methods and systems for autoinduction of protein expression
ADAGENE INC0 citations50